Earliest interbreeding event between ancient human populations discovered

The study documented the earliest known interbreeding event between ancient human populations— a group known as the “super-archaics” in Eurasia interbred with a Neanderthal-Denisovan ancestor about 700,000 years ago. The event was between two populations more distantly related than any other recorded.

Rounds with Leadership: The Year of the Nurse Educator

The World Health Organization has designated 2020 as the International Year of the Nurse and the Midwife to celebrate the more than 22 million nurses and 2 million midwives who make up half of the global health workforce (WHO, 2020). These providers are vital to sustaining health and well-being in all communities in which they serve. Beyond raising awareness about nursing’s contribution to society, WHO also wants to use this designation to highlight the need for greater investments in the nursing workforce with the goal of ending the ongoing shortage of registered nurses (RNs).

Addition of Immunotherapy to Standard Treatment for Advanced Stage Non-Small Cell Lung Cancer is Safe and Tolerable as First-Line Therapy

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer (NSCLC).

John Theurer Cancer Center Launches Clinical Trial of Personalized Cancer Vaccine Using New Gene-Based Technology for High-Risk Melanoma

John Theurer Cancer Center at Hackensack University Medical Center is the only site in New Jersey and one of just 17 in the country participating in a multicenter international Phase II study of an innovative personalized cancer vaccine being evaluated in combination with pembrolizumab immunotherapy in patients with melanoma that has been surgically removed but has a high risk of coming back. The hope is that the vaccine can prime a patient’s immune system to be more responsive to immunotherapy and reduce the risk of cancer recurrence.

ATS Foundation Research Program/Pulmonary Hypertension Association Names 2019 Partner Grant Awardees

The ATS Foundation Research Program/Pulmonary Hypertension Association has awarded Rahul Kumar, PhD, of the University of California, San Francisco, a $80,000 Foundation Partner grant. A $50,000 Foundation Partner grant was awarded to Jason Boehme, MD, also of the University of California, San Francisco. Ke Yuan, PhD, of Boston Children’s Hospital is the 2019 recipient of the Aldrighetti Research Award for Young Investigators. The award, in the amount of $80,000, is sponsored by Actelion Pharmaceuticals US, Inc, through a partnership with the Pulmonary Hypertension Association.

Tulane University launches new coronavirus research program to develop a vaccine and advanced diagnostics

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.

UAH research into developing artificial lymph nodes has immunotherapy implications

Research into engineering artificial organs that mimic the functions of human lymph nodes at The University of Alabama in Huntsville (UAH) has garnered one of its professors a $507,777 National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) Award.

ORNL, TVA sign agreement to collaborate on advanced reactor technologies

The U.S. Department of Energy’s Oak Ridge National Laboratory and the Tennessee Valley Authority have signed a memorandum of understanding to evaluate a new generation of flexible, cost-effective advanced nuclear reactors.

أمل جديد لمرضى داء الانسداد الرئوي المزمن بفضل جهاز يُستخدم في المنزل

في ورقة بحثية جديدة نُشِرت بتاريخ 4 فبراير في شبكة JAMA, وصف باحثون من Mayo Clinic فوائد علاج تنفسي منزلي غير باضع ― يشتمل على نوع يُشار إليه بضغط مجرى التنفس الموجب ثنائي المستوى أو BiPAP ― لكثير من المرضى المصابين بداء الانسداد الرئوي المزمن. وذكر الفريق عددًا من الفوائد منها انخفاض الوفيات وانخفاض حالات دخول المستشفيات، وتقليل خطورة التنبيب وتحسن حالات ضيق التنفس وانخفاض عدد زيارات أقسام الطوارئ.

دراسة من Mayo Clinic: الفحص الوعائي المبكِّر عامل رئيسي للحد من خطورة إصابات النساء بأمراض القلب

ثمة اختلاف في الطريقة التي يشيُّخ فيها نظام الأوعية الدموية ومعدَّل تقدُّم مرض تصلُّب الشرايين (زيادة سُمك جدران الشريان أو تكوُّن الانسداد الشرياني) بين الرجال والنساء مع مرور الوقت وتؤثر هذه الاختلافات المرتبطة بالنوع والعمر بشكل مباشر على عوامل إصابة النساء بالأمراض القلبية الوعائية.

A deep dive into cellular aging

Scientists at Sanford Burnham Prebys Medical Discovery Institute and Harvard University have discovered that mitochondria trigger senescence, the sleep-like state of aged cells, through communication with the cell’s nucleus—and identified an FDA-approved drug that helped suppress the damaging effects of the condition in cells and mice. The discovery, published in Genes & Development, could lead to treatments that promote healthy aging or prevent age-associated diseases such as cancer, Alzheimer’s disease, heart disease and more.

Columbia University researchers awarded $2M to identify antiviral drugs for coronavirus

Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV. The funding was awarded by the Jack Ma Foundation,…